knowledge -WSS

knowledge

author：leisure time 2025-09-06 04:33:43 - browse：34

Scientist Nour Tabidi prepares a DNA sample in a lab. -- health coverage from STAT — Scientist Nour Tabidi prepares a DNA sample in a lab at Thermo Fisher's recently opened manufacturing plant in Plainville. John Tlumacki/Globe Staff

Thermo Fisher Scientific’s giant plant to manufacture gene therapies for drug companies is barely a year old, but executives at the maker of scientific tools are already talking about expanding.

Standing inside a cavernous unfinished section of the plant, Paul Fitzgerald, vice president and general manager of the site, told a group of biotech executives, journalists, and other visitors that he’s eager to transform it into laboratories. So far, the company is only using about 290,000 of the plant’s more than 400,000 square feet.

“I look forward to you guys giving us a reason to fill up this space,” Fitzgerald quipped during a tour Tuesday of the plant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Telehealth startups are trying to fill the menopause care vacuum

hotspot

WSS

Scientific mystery highlights the blind spots in genomics databases

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Young boy dies in trial for Pfizer Duchenne gene therapy

Telehealth startups are trying to fill the menopause care vacuum

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Mystery swirls around US soldier who entered North Korea days ago, officials say

entertainment

knowledge

focus

Psychedelics group wrestles with new pharma identity

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Affirmative action in medical school literally saved lives

5 dead in mass shooting on Caribbean island of St. Vincent: Police

BioMarin wins approval for gene therapy to treat hemophilia A

The stock market has soared this year, but will it last? Experts weigh in

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Covid silver lining: Unprecedented look at human immune system

Medical leaders decry Supreme Court decision on affirmative action

Scientists grapple with ethics of stem cell research

hotspot

When a patient nears the end, a feared therapy can comfort

The stock market has soared this year, but will it last? Experts weigh in

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Drug companies' payments and gifts affect physicians' prescribing

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Judge denies Trump's request for new trial in E. Jean Carroll case

focus

hotspot

hotspot

explore